Company: BLTE
Filing Date: 2025-12-02
Form Type: 424B5
Source: 0001104659-25-117702
Chunk: 7

Company: BELITE BIO, INC
Filing Date: 2025-12-02
Form: 424B5
Chunk 7
---
, including our estimates of the number of patients who suffer from the diseases we are targeting;

•

estimates of our costs, expenses, future revenues, capital expenditures and our needs for additional financing;

•

our ability to attract and retain senior management and key employees;

•

our future business development, financial condition and results of operations;

•

future developments, trends, conditions and competitive landscape in the industry and markets in which we operate;

•

our strategies, plans, objectives and goals and our ability to successfully implement these strategies, plans, objectives and goals;

<div align='center'>S-2</div>

TABLE OF CONTENTS

•

costs associated with enforcing or defending against intellectual property infringement, misappropriation or violation, product liability and other claims;

•

our ability to establish and maintain collaborations or licensing agreements;

•

our ability to identify and integrate new product candidates, technologies and/or suitable acquisition targets;

•

our ability to effectively manage our growth;

•

changes to regulatory and operating conditions in our industry and markets; and

•

the potential impact of epidemics, pandemics or other public health issues on our current and future business development, financial condition and results of operations.

The “ Risk Factors ” section of this prospectus supplement, the accompanying prospectus, and our Annual Reports on Form 20-F and reports on Form 6-K filed with the SEC and incorporated by reference into this prospectus supplement or the accompanying prospectus discusses the principal contingencies and uncertainties to which we believe we are subject, which should be considered in evaluating any forward-looking statements contained or incorporated by reference in this prospectus supplement or in the accompanying prospectus.

<div align='center'>S-3</div>

TABLE OF CONTENTS

### PROSPECTUS SUPPLEMENT SUMMARY
This summary highlights selected information about us, this offering and information contained in greater detail elsewhere in this prospectus supplement, the accompanying prospectus, any free writing prospectus that we have authorized for use, and in the documents incorporated by reference. This summary is not complete and does not contain all of the information that you should consider before investing in our ADSs. You should carefully read and consider this entire prospectus supplement, the accompanying prospectus and the documents and other information incorporated by reference into this prospectus supplement, including the financial statements and related notes incorporated by reference herein, and “Risk Factors” starting on page S-12 of this prospectus supplement, before making an investment decision. If you invest in the ADSs, you are assuming a high degree of risk.

### Our Business

###